Taipei Exchange - Delayed Quote TWD
Advagene Biopharma Co., Ltd. (6709.TWO)
15.90
-0.30
(-1.85%)
At close: 2:16:53 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Yu-Shen Hsu | Chairman & GM | -- | -- | -- |
| Mr. Chen Bryon | Founder & Director | -- | -- | -- |
| Kuangdun Su | Accounting Supervisor | -- | -- | -- |
| Frank Hsiao | Executive Vice President | -- | -- | -- |
Advagene Biopharma Co., Ltd.
No. 308, Neihu Road
6th Floor Section 1 Neihu District
Taipei, 114
Taiwan
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 12
Description
Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. Its products in development include nasal spray influenza vaccine, allergy vaccines, and COVID-19 immunotherapy. The company is based in Taipei, Taiwan.
Corporate Governance
Advagene Biopharma Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
7754.TWO AnnJi
19.70
0.00%
6892.TWO Taiwan Bio Therapeutics Co., Ltd
30.00
-1.64%
7729.TWO SBI
22.75
+2.02%
6564.TWO Enimmune corporation
18.55
-1.33%
6827.TWO MegaPro Biomedical Co., Ltd
9.68
-0.10%
6814.TWO Lukas Biomedical Inc.
24.60
0.00%
6810.TWO Bio Preventive Medicine Corp.
23.45
-0.21%
4170.TWO VBI
13.15
+0.77%
4724.TWO Meribank Biotech Co., Ltd
14.30
-3.38%
6986.TWO HeXun Biosciences Co., Ltd.
74.90
-1.19%